Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2012-03-09Clinical Trial Update: Comparing the Efficacy of the ConvaTec Engenex® Negative Pressure Wound Therapy Device to Moist Wound Therapy [Phase 4]
A Phase 4 trial comparing the ConvaTec Engenex negative pressure wound therapy device to moist wound therapy for diabetic foot wounds has be…
-
CLINICAL_TRIALS withdrawal · 2012-03-06Clinical Trial Update: Comparison of Amlodipine and Aliskiren in Diabetic Hypertensive Patient With Blood Pressure Not Controlled by Losartan [Phase 4]
A Phase 4 trial comparing amlodipine and aliskiren in diabetic patients with hypertension not controlled by losartan has been withdrawn. The…
-
CLINICAL_TRIALS withdrawal · 2011-07-26Clinical Trial Update: A1c Discordance in Diabetes Patients [NA]
The clinical trial NCT01213277 investigating A1c discordance in diabetes mellitus has been suspended.
-
EMA withdrawal · 2009-04-17EMA Withdrawn: Velosulin (Insulin human) — Novo Nordisk A/S
Velosulin (insulin human) has been withdrawn from the market in the EU.
-
EMA withdrawal · 2008-11-16EMA Withdrawn: Exubera (Insulin human) — Pfizer Limited
EMA withdrew Exubera (insulin human) from the market; the product is no longer authorized for use in diabetes mellitus patients.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2008-02-21Clinical Trial Update: A Clinical Trial Assessing the Impact of Inhaled Insulin on Glucose Disposition [Phase 3]
Pfizer-sponsored Phase 3 trial evaluating inhaled insulin for diabetes mellitus has been terminated.
-
EMA withdrawal · 2008-02-14EMA Withdrawn: Monotard (Insulin human) — Novo Nordisk A/S
The EMA indicates Monotard (insulin human) has been withdrawn from the market.
-
EMA withdrawal · 2008-02-14EMA Withdrawn: Ultratard (Insulin human) — Novo Nordisk A/S
Ultratard (insulin human) has been withdrawn from the market in the European Union.
-
EMA withdrawal · 2008-01-16Marvel LifeSciences Ltd withdraws its marketing authorisation applications for Insulin Human Rapid Marvel, Insulin Human Long Marvel and Insulin Human 30/70 Mix Marvel
Marvel LifeSciences Ltd has withdrawn its marketing authorization applications for three insulin products: Insulin Human Rapid Marvel, Insul…
-
EMA withdrawal · 2008-01-16EMA Application withdrawn: Insulin Human Long Marvel (human insulin) — Marvel LifeSciences Ltd.
The EMA has withdrawn the application for Insulin Human Long Marvel (human insulin) by Marvel LifeSciences Ltd. for diabetes mellitus.
-
EMA withdrawal · 2008-01-16EMA Application withdrawn: Insulin Human Rapid Marvel (human insulin) — Marvel LifeSciences Ltd.
Application withdrawn for Insulin Human Rapid Marvel (human insulin) by Marvel LifeSciences Ltd. for diabetes mellitus.
-
EMA withdrawal · 2008-01-16EMA Application withdrawn: Insulin Human 30/70 Mix Marvel (human insulin) — Marvel LifeSciences Ltd.
The EMA withdrew the application for Insulin Human 30/70 Mix Marvel (human insulin) by Marvel LifeSciences Ltd. for diabetes treatment.
-
CLINICAL_TRIALS withdrawal · 2007-04-30Clinical Trial Update: Sub-Cutaneous Insulin in Hyperglycaemic Emergencies [NA]
A clinical trial evaluating subcutaneous insulin for hyperglycemic emergencies has been withdrawn. The study was sponsored by The Royal Bour…